ISSN: 2332-0877

Journal des maladies infectieuses et de la thérapie

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Plant Based Molecules for the Management of Covid-19

Yogesh Arun Dound, Sameer Chaudhary, Rajesh Sehgal, Sapana Sameer Chaudhary and Bhushan Arun Dound

COVID-19 pandemic has put forward a serious challenge to the global research community to find a therapeutic solution for the
disease. Nations are collaborating to fast track the development of the vaccine, but with a very limited or no success. Considering Corona
virus being a RNA virus, development of vaccine will have its own challenges and may take more time than the desire or expected time.
Natural Products and phytoactives from the plants, which are commonly used globally for the management of various viral diseases, can
offer the ray of hope as natural supportive modalities. In the current study, 20 ligands of plant origin were selected after thorough literature
survey and were studied for their potential antiviral characteristics using in silico techniques. The study focuses on Main Protease (Mpro)
and SARS corona virus main peptidase. These ligands were screened for being the potential drug targets and most of the selected
compounds have shown significant binding energies suggesting that these can be further explored to find an effective anti-viral treatment.